Antibiotic Prophylaxis in Urology Departments, 2005-2010

dc.authoridPereira, Bruno Jorge/0000-0001-6537-1388
dc.authoridHeldwein, Flavio Lobo/0000-0003-4321-0078
dc.authoridtandogdu, zafer/0000-0002-5309-3656
dc.authoridSacco, Emilio/0000-0003-4640-8354
dc.authoridbjerklund johansen, truls erik/0000-0003-3490-6460
dc.authorwosidPereira, Bruno Jorge/J-1371-2019
dc.authorwosidNaber, Kurt/AAR-9997-2020
dc.authorwosidHeldwein, Flavio Lobo/G-9603-2013
dc.contributor.authorCek, Mete
dc.contributor.authorTandogdu, Zafer
dc.contributor.authorNaber, Kurt
dc.contributor.authorTenke, Peter
dc.contributor.authorWagenlehner, Florian
dc.contributor.authorvan Oostrum, Edgar
dc.contributor.authorKristensen, Brian
dc.date.accessioned2024-06-12T11:03:03Z
dc.date.available2024-06-12T11:03:03Z
dc.date.issued2013
dc.departmentTrakya Üniversitesien_US
dc.description.abstractBackground: Antibiotic prophylaxis (AP) is an important measure in preventing health care-associated urinary tract infections (HAUTIs). Despite regional variations in the bacterial spectrum and antibiotic susceptibility patterns, guideline recommendations are usually given on an international level. Objective: To describe the use of AP in urology departments and relate this to relevant parameters such as country, type of hospital, and European Association of Urology guideline recommendations. Design, setting, and participants: Data from the Global Prevalence Study on Infections in Urology for the period 2005-2010 were analysed to evaluate the use of antibiotics in general and AP for urologic procedures. Of the 13 723 patients enrolled, 8178 received antibiotics on the study days. Outcome measurements and statistical analysis: Study data were imported from the Web-based survey into Microsoft Access and exported into SPSS v. 17.0. The data were then coded and analysed. The Pearson chi-Square test was used to compare categorical data and a probability level of 5% was considered significant. Multiple logistic regression analysis was used to define significantly different variables in multiple set categories. Results and limitations: Questions on AP were answered on 8370 forms and 6306 (75.3%) investigators reported their routine application of AP. Routine AP was highest in Latin America (n = 337; 84%), followed by Asia (n = 1338; 86%), Africa (n = 234; 85%), and Europe (n = 4116; 67%). The antibiotics most frequently used for AP were second-generation cephalosporins, ciprofloxacin, cefotaxime, and amoxicillin plus beta-lactamase inhibitor. Conclusions: There were significant differences between countries/regions and types of hospitals, both in using AP for clean procedures and in the types of antibiotics used. AP was not always consistent with recommended guidelines. (C) 2012 European Association of Urology. Published by Elsevier B.V. All rights reserved.en_US
dc.description.sponsorshipEuropean Association of Urologyen_US
dc.description.sponsorshipEuropean Association of Urology.en_US
dc.identifier.doi10.1016/j.eururo.2012.09.038
dc.identifier.endpage394en_US
dc.identifier.issn0302-2838
dc.identifier.issn1873-7560
dc.identifier.issue2en_US
dc.identifier.pmid23031676en_US
dc.identifier.scopus2-s2.0-84871921117en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage386en_US
dc.identifier.urihttps://doi.org/10.1016/j.eururo.2012.09.038
dc.identifier.urihttps://hdl.handle.net/20.500.14551/21496
dc.identifier.volume63en_US
dc.identifier.wosWOS:000313572100035en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofEuropean Urologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHealthcare-Associated Urinary Tract Infections (HAUTI)en_US
dc.subjectAntimicrobial Prophylaxisen_US
dc.subjectEAU Guidelinesen_US
dc.subjectAntimicrobial Useen_US
dc.subjectInfectious Complicationsen_US
dc.subjectResistanceen_US
dc.subjectPrevalenceen_US
dc.subjectReassessen_US
dc.titleAntibiotic Prophylaxis in Urology Departments, 2005-2010en_US
dc.typeArticleen_US

Dosyalar